NCT04458597View on ClinicalTrials.gov

Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus.

NACompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

August 26, 2020

Primary Completion Date

May 2, 2024

Study Completion Date

May 14, 2024

Conditions
Endometrioid AdenocarcinomaSerous CarcinomaClear Cell CarcinomaCarcinosarcomaDedifferentiated Carcinoma
Interventions
RADIATION

Image-guided adjuvant pelvic radiotherapy

Image-guided adjuvant pelvic radiotherapy delivered at an SBRT prescription dose of 30 Gy in 5 fractions if feasible, well-tolerated and effective for the adjuvant treatment of high-risk endometrial cancer.

Trial Locations (1)

N6A 5W9

London Regional Cancer Program, London

All Listed Sponsors
lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

NCT04458597 - Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus. | Biotech Hunter | Biotech Hunter